BioSpace News Archive

- The success of the procedure unleashes a new era for retrievable interventional cardiac valve technology in China [28-November-2017] HANGZHOU, China, Nov. 28, 2017 /PRNewswire/ -- The first human implantation of the VenusA Plus retrievable valve system was completed successfully at the Second Affiliated Hospital of Zhejiang University School of Medicine (SA

GenePOC is proud to announce the launch of its 2nd FDA cleared assay in less than 6 months, GenePOC CDiff, for use on the revogene instrument.

Q Biomed announced today that Dr. Helen Tager-Flusberg from Boston University has joined its advisory committee for QBM-001, which is being tested for pediatric developmental nonverbal disorder in toddlers within the autism spectrum disorders.

The power of dedicated research, and discovery of new gene mutation variants help develop much-needed treatments.

Our new formulary will target four aspects of this illness inflammation, airway constriction, capacity, and anxiety.

Mr. Cross has over twenty years of experience, with executive leadership roles in both private and public biotechnology companies.

The University of Washington used the Nortis ParVivo system in this study that was published in JCI Insights and highlighted as its cover article.

Carestream Systems enhance reading of MR, CT, X-ray imaging studies and enable physicians to expedite delivery of diagnosis to patients.

Newly published research in the Journal of Molecular and Cellular Proteomics describes a collection of autoantibody biomarkers for early detection of lung cancer.

This is a significant step in preparing for PharmaCyte’s pancreatic cancer clinical trial.